Javascript must be enabled to continue!
Digoxin-quinidine interaction in patients with chronic renal failure.
View through CrossRef
We evaluated the effect of quinidine on digoxin pharmacokinetic in six patients with severe renal failure. Quinidine reduced the total body clearance of digoxin from 1.87 to 1.06 l/hour (p less than 0.001), and prolonged the digoxin half-life of elimination from 5.20 to 9.61 days (p less than 0.01). The digoxin volume of distribution was unchanged. Renal clearance of digoxin was negligible; thus, the decrease in total body clearance was due to a decrease in the nonrenal clearance of digoxin. The mean trough serum concentrations of quinidine ranged from 1.0 to 3.0 micrograms/ml. We conclude that in patients with chronic renal failure, the dose of digoxin should be decreased by 50% if quinidine therapy is initiated.
Ovid Technologies (Wolters Kluwer Health)
Title: Digoxin-quinidine interaction in patients with chronic renal failure.
Description:
We evaluated the effect of quinidine on digoxin pharmacokinetic in six patients with severe renal failure.
Quinidine reduced the total body clearance of digoxin from 1.
87 to 1.
06 l/hour (p less than 0.
001), and prolonged the digoxin half-life of elimination from 5.
20 to 9.
61 days (p less than 0.
01).
The digoxin volume of distribution was unchanged.
Renal clearance of digoxin was negligible; thus, the decrease in total body clearance was due to a decrease in the nonrenal clearance of digoxin.
The mean trough serum concentrations of quinidine ranged from 1.
0 to 3.
0 micrograms/ml.
We conclude that in patients with chronic renal failure, the dose of digoxin should be decreased by 50% if quinidine therapy is initiated.
Related Results
Clinical signs and symptoms of toxic serum digoxin levels in neonates
Clinical signs and symptoms of toxic serum digoxin levels in neonates
Digoxin is widely used in the treatment of congestive heart failure and some arrhythmias. Digoxin toxicity may occur easily because digoxin has a narrow therapeutic index. This ret...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
Background: Digoxin is extensively prescribed for cardiac diseases, so its chronic or acute toxicity commonly occur. Although digoxin specific antibodies (anti-digoxin Fab) are rec...
Radioimmunoassay of Digoxin—Interference by Digitoxin
Radioimmunoassay of Digoxin—Interference by Digitoxin
Abstract
Digitoxin interference with radioimmunoassay of digoxin may present a problem in determining digoxin concentrations in the serum of patients treated with di...
Surveillance of Digoxin Concentrations in Critically Ill Individuals with Heart Failure
Surveillance of Digoxin Concentrations in Critically Ill Individuals with Heart Failure
Background and Objectives: Digoxin is a pharmacological agent of natural origin that is still occasionally administered in the intensive care unit (ICU). The objective of this stud...
ASSA13-13-6 Clinical Study of Prenatal Trans-Placental Digoxin Therapy For Fetal Heart Failure
ASSA13-13-6 Clinical Study of Prenatal Trans-Placental Digoxin Therapy For Fetal Heart Failure
Objective
Study the clinical efficacy and safety of transplacental digoxin therapy for foetal heart failure. Investigate the evaluation and treatment guiding valu...
Effect of Digoxin on Ejection Fraction in Elderly Patients with Congestive Heart Failure
Effect of Digoxin on Ejection Fraction in Elderly Patients with Congestive Heart Failure
To assess the effect of oral digoxin on left ventricular systolic function in elderly patients, radionuclide angiography was performed on 20 patients 74 years old or older before a...

